← Leaderboards
Stephan A Grupp
University Of Pennsylvania
$7,570,044
Attributed
$10,060,825
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,060,825 · 10
By mechanism
R01$3,990,678 · 3
U01$3,651,996 · 1
UE5$997,175 · 1
R21$660,600 · 1
P30$630,531 · 3
R29$129,845 · 1
Top collaborators
- Elizabeth O Hexner3 shared
- David A Mankoff3 shared
- Evan William Weber1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Lewis A Chodosh$38,386,361
- Edward J Gunther$5,558,883
- Angela Demichele$6,304,623
- Mariusz A Wasik$8,531,349
- David A Mankoff$17,196,499
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsLeukemiaClinical TrialsChildhoodChildResearch PersonnelRelapseDesignTranslatingProtocols DocumentationTranslational ResearchAreaPharmaceutical PreparationsChildhood LeukemiaResponseBaseImmunotherapyClinical ResearchCellsFundingBiologyBasic ScienceCollaborations
Grant awards (28)
Pediatric Oncology Program$131,811
P30 · FY2025 · CA · contact PI
Pediatric Oncology Program$82,883
P30 · FY2024 · CA · contact PI
Pediatric Oncology Program$82,880
P30 · FY2023 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$338,745
UE5 · FY2022 · CA
Pediatric Oncology Program$84,182
P30 · FY2022 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$338,745
UE5 · FY2021 · CA
Pediatric Oncology Program$98,432
P30 · FY2021 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$319,685
UE5 · FY2020 · CA
Pediatric Oncology Research Program$75,137
P30 · FY2020 · CA · contact PI
Defining and overcoming intrinsic T cell dysfunction to enable pediatric immunotherapy$3,651,996
U01 · FY2019 · CA · contact PI
Pediatric Oncology Research Program$75,206
P30 · FY2019 · CA · contact PI
Determinants of Relapse Risk After BMT for ALL$293,737
R01 · FY2011 · CA · contact PI
Determinants of Relapse Risk After BMT for ALL$303,263
R01 · FY2010 · CA · contact PI
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA$320,964
R01 · FY2009 · CA · contact PI
Determinants of Relapse Risk After BMT for ALL$297,760
R01 · FY2009 · CA · contact PI
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA$311,617
R01 · FY2008 · CA · contact PI
Determinants of Relapse Risk After BMT for ALL$289,644
R01 · FY2008 · CA · contact PI
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA$308,531
R01 · FY2007 · CA · contact PI
Determinants of Relapse Risk After BMT for ALL$304,189
R01 · FY2007 · CA · contact PI
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA$308,491
R01 · FY2006 · CA · contact PI
POST TRANSPLANT T CELL RECONSTITUTION IN NEUROBLASTOMA$321,780
R21 · FY2005 · CA
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA$306,715
R01 · FY2005 · CA
POST TRANSPLANT T CELL RECONSTITUTION IN NEUROBLASTOMA$338,820
R21 · FY2004 · CA
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE$243,768
R01 · FY2003 · CA
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE$241,439
R01 · FY2002 · CA
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE$233,667
R01 · FY2001 · CA
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE$226,893
R01 · FY2000 · CA
BCR COMPLEX IN B CELL DEVELOPMENT AND ALLELIC EXCLUSION$129,845
R29 · FY2000 · AI